Publications in collaboration with researchers from Universidad Nacional Autónoma de México (16)

2023

  1. Field study of parasitic contamination of fruits, vegetables and leafy greens in the Ecuadorian Andes

    F1000Research, Vol. 12

2022

  1. Transdermal formulations and strategies for the treatment of osteoporosis

    Journal of Drug Delivery Science and Technology, Vol. 69

2018

  1. First phenotypic and genotypic description of Fasciola hepatica infecting highland cattle in the state of Mexico, Mexico

    Infection, Genetics and Evolution, Vol. 64, pp. 231-240

2016

  1. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo

    European Journal of Pharmaceutical Sciences, Vol. 85, pp. 31-38

2013

  1. Fascioliasis and Intestinal Parasitoses Affecting Schoolchildren in Atlixco, Puebla State, Mexico: Epidemiology and Treatment with Nitazoxanide

    PLoS Neglected Tropical Diseases, Vol. 7, Núm. 11

  2. Polymeric nanospheres as strategy to increase the amount of triclosan retained in the skin: Passive diffusion vs. iontophoresis

    Journal of Microencapsulation, Vol. 30, Núm. 1, pp. 72-80

2011

  1. Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation

    Pharmaceutical Development and Technology, Vol. 16, Núm. 2, pp. 162-169

2010

  1. Comparing metoclopramide electrotransport kinetics in vitro and in vivo

    European Journal of Pharmaceutical Sciences, Vol. 41, Núm. 2, pp. 353-359

  2. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: Effect of experimental parameters and skin type on drug stability and transport kinetics

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 75, Núm. 2, pp. 173-178

  3. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies

    European Journal of Pharmaceutical Sciences, Vol. 39, Núm. 5, pp. 387-393

2009

  1. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation

    Current Drug Discovery Technologies, Vol. 6, Núm. 3, pp. 171-185

2008

  1. Phylogeography and genetic variation of Triatoma dimidiata, the main chagas disease vector in Central America, and its position within the genus Triatoma

    PLoS Neglected Tropical Diseases, Vol. 2, Núm. 5

  2. The tape-stripping technique as a method for drug quantification in skin

    Journal of Pharmacy and Pharmaceutical Sciences, Vol. 11, Núm. 1, pp. 104-130

2007

  1. Genome size determination in Chagas disease transmitting bugs (hemiptera-triatominae) by flow cytometry

    American Journal of Tropical Medicine and Hygiene, Vol. 76, Núm. 3, pp. 516-521

2006

  1. Chromosomal variation and genome size support existence of cryptic species of Triatoma dimidiata with different epidemiological importance as Chagas disease vectors

    Tropical Medicine and International Health, Vol. 11, Núm. 7, pp. 1092-1103

2001

  1. The ITS-2 of the nuclear rDNA as a molecular marker for populations, species, and phylogenetic relationships in Triatominae (Hemiptera: Reduviidae), vectors of Chagas disease

    Molecular Phylogenetics and Evolution, Vol. 18, Núm. 1, pp. 136-142